Marrowforums (
-   Clinical Trials (
-   -   Trial on rigosertib (

Lennyr Mon Jan 23, 2017 03:54 PM

Trial on rigosertib
My 75 year old husband is being considered for a trial on rigosertib. We are weighing the pluses and minuses. Has anyone gone through this trial . What is your experience on it . Thank you

Neil Cuadra Mon Jan 23, 2017 07:42 PM

Since Vidaza didn't help your husband, it sounds like he's a prime candidate for the new rigosertib Phase 3 trial, which is currently recruiting patients.

This trial is unusual in that it stemmed from a previous trial that was unsuccessful overall in extending MDS patient survival (comparing rigosertib treatment to standard care). However, statistics from that study showed that rigosertib helped survival for patients who had no response to Vidaza (or another hypomethylating agent).

With the new study, researchers will study this effect for high-risk MDS patients. It's strange to think that having no response to Vidaza may actually be better for a patient than having a partial response or a response and relapse, if rigosertib is available to them.

All times are GMT -4. The time now is 11:46 AM.

Powered by vBulletin® Version 3.6.7
Copyright ©2000 - 2021, Jelsoft Enterprises Ltd.
Forum sites may contain non-authoritative and unverified information.
Medical decisions should be made in consultation with qualified medical professionals.
Site contents exclusive of member posts Copyright 2006-2020